In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1877 News Items found
Dr. Eileen O'Reilly seen with patient Leanna Stokes and MSK nurse Tiffany Upshaw
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
MSK physician-scientist Vinod Balachandran.
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing

Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
MSK Doctors Andrea Cercek and Michael Foote are seen smiling.
Treating HER2-Amplified Early-Stage Rectal Cancer To Improve Quality of Life

Learn how rectal cancer patients with HER2 driven tumors benefited from an early stage clinical trial at MSK.
Scott Lowe and Dana Pe'er
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped

An MSK study reveals new details about how pancreatic cells carrying oncogenic mutations transition from benign to malignant — shining new light on the ecosystems that supports emerging tumors.
Christopher Lima
Dr. Christopher Lima Elected AAAS Fellow

Sloan Kettering Institute Structural Biology Program Chair Dr. Christopher Lima was elected to the 2025 class of American Association for the Advancement of Science Fellows.
whole fresh turmeric root beside a bowl of turmeric powder
The Truth About Turmeric and Cancer

Can turmeric fight cancer? Learn more from an MSK expert about what the science says.
Reicy Bobadilla stands in front of a window with the MSK logo on it
What You Should Know About Mesothelioma in Younger Patients

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.
Scott Lowe
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
Microscope in foreground, MSK researchers in the background.
MSK Research Highlights, March 27, 2026

New MSK research finds skin stem cells retain long-lasting memory of inflammation; shows how a large cancer DNA study could transform personalized oncology; reveals how the protein BAF helps cancer cells hide from the immune system; and investigates how early DNA markings shape cell fate.
MSK's Wungki Park, MD, seen smiling in laboratory.
First-in-Class Investigational Drug KRAS G12D Degrader Shows Promise in Lung and Pancreatic Cancers

Learn how a novel drug is showing promise against lung and pancreatic cancer in early clinical trials by targeting the KRAS G12D mutation with a KRAS degrader.